PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
author
Lankin, Vadim Z.
Tikhaze, Alla K.
Viigimaa, Margus
Chazova, Irina Evgenevna
statement of authorship
V.Z. Lankin, A.K. Tikhaze, M. Viigimaa, I.E. Chazova
source
Terapevticheskii Arkhiv
publisher
CJSC Consilium Medicum
journal volume number month
Vol. 90, 9
year of publication
2018
pages
p. 27-30
url
https://doi.org/10.26442/terarkh201890927-30
subject term
antioksüdandid
ensüümid
kolesterool
ravimid
inhibiitorid
lipoproteiinid
keyword
antioxidant enzymes
cholesterol-lowering drugs
inhibitor of PCSK9
oxidized low-density lipoproteins
ISSN
0040-3660
notes
Bibliogr.: 15 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
Scopus
https://www.scopus.com/sourceid/19655
https://www.scopus.com/record/display.uri?eid=2-s2.0-85054532322&origin=resultslist&sort=plf-f&src=s&sid=453b52ade09d39dafbc80e3146572c7a&sot=b&sdt=b&s=DOI%2810.26442%2Fterarkh201890927-30%29&sl=36&sessionSearchId=453b52ade09d39dafbc80e3146572c7a&relpos=0
WOS
https://jcr.clarivate.com/jcr-jp/journal-profile?journal=TERAPEVT%20ARKH&year=2022
https://www.webofscience.com/wos/woscc/full-record/WOS:000450869600004
category (general)
Arts and humanities
Kunst ja humanitaarteadused
Medicine
Meditsiin
category (sub)
Arts and humanities. History
Kunst ja humanitaarteadused. Ajalugu
Medicine. Family practice
Meditsiin. Perepraktika
Medicine. Internal medicine
Meditsiin. Sisehaigused
quartile
Q4
TalTech department
tervisetehnoloogiate instituut
language
inglise